Advanced Clinical的动态

In Clinical trials, the early stages are make-or-break. Efficient site activation and thorough documentation is not optional, it is the foundation for smooth, timely, and cost-effective trials. You can read a little more below on how to simplify these crucial steps for the most successful outcomes:

Overly complex clinical trial designs cause various problems in clinical development. Our analysis reveals that an excessive number of outcome measures hinders patient enrollment and burdens participants. Fortunately, Phesi offers a straightforward solution to streamline outcome measures in clinical trials. #clinicaldevelopment #clinicaltrials #protocoldesign

Nobody talks about the speed with which you can #enrollpatients and close your study enrollment if you include #diversepatients. The more diverse your patient population is, the bigger the pool of patients. This article takes an in-depth look at optimizing clinical trials through diversity. As well as the importance and the steps that we can take to support sites in becoming more diverse. We recently had a webinar where we invited industry experts on diversity and patient enrollment to share their knowledge. The article will also dive into case examples from the Children's Hospital of Philadelphia and the research of American Society for Clinical Pharmacology & Therapeutics. The importance of clinical trial diversity is unquestionable. Finding a strategic and sustainable way to design successful and efficient trials while keeping it diverse - is absolutely possible. Start today, with patient feasibility. #clinicaltrials #decentralizedclinicaltrials #clinicaltrialplanning #clinicalresearch #optimizetrialplanning #patientsfirst #patientdiversity #patientburden

Each phase of clinical development comes with its own challenges and cost considerations, influenced by factors like trial size, scope, and duration. From safety assessments in phase 1 to large-scale efficacy studies in phase 3, discover the strategies that can help you optimize costs without compromising your data quality. https://hubs.li/Q02RrYpc0 #ClinicalTrials #CostOptimization #CRO #ClinicalResearch #SouthernStarResearch

Choosing the right Clinical Research Organization (CRO) can make or break your clinical trial. How do you ensure you pick the best one for your needs? Discover how to make an informed decision for seamless trial execution in this quick guide: https://hubs.li/Q02GkCFn0 #ClinicalTrials #CRO #SouthernStarResearch

In the latest #TalkClinicalTrials blog, learn more about the barriers to #type1diabetes clinical trial participation and JDRF/FRDJ Canada's new T1D Clinical Trials Finder. Read the blog post here: https://bit.ly/48SNR6D #ClinicalTrials #ClinicalTrialParticipation

Construction of Digital Patient Profile (DPP) can lead to Digital Twin, optimizing clinical trial design to avoid costly protocol amendments. Additionally, DPP can identify investigator sites with proven access to patients you aim to treat. #DigitalHealth #ClinicalTrials #HealthcareTechnology #clinicaldevelopment

There is increasing momentum behind the Joint Clinical Assessment before it is implemented next January in the European Union. Read the latest updates and what the JCA could mean for patients in member states at https://hubs.li/Q02n2h3v0 #PatientsFirst #EMA #PatientAccess #MarketAccess

?? Celebrating diversity in everything? Well, we're still not done - time to embrace it in Clinical trials, too?? In the ever-evolving realm of medical research, there's a critical challenge the industry must address: how do we balance the need for diverse patient representation with the need for efficient site performance? ?? This article is shedding light on the importance of incorporating diversity as a foundational aspect of clinical trial design, rather than just an afterthought. ?? From fostering strong community partnerships to leveraging technology for accessibility, it covers actionable strategies to ensure that diversity enhances, rather than complicates, trial execution. And it's not just about theory; there are already some real-world success stories Everyone's aware of the many issues with the industry - it's about time we start revolutionizing clinical trials, making them more inclusive, efficient, and impactful for all! ?? #ClinicalResearch #DiversityandInclusion #InnovateClinicalTrials

#innovative #clinicaltrialdesigns can make clinical trials work better for everyone involved - including #patients and FDA as well as #drugsponsors and #trialsites. For instance, pragmatic clinical trials integrate clinical trials into routine healthcare settings including primary care; Bayesian trials are better suited for the realities faced in many rare disease trials including frequent trial monitoring, interim decision-making, and hierarchical modeling; and Selective Safety Data Collection (#SSDC) strategically streamlines data collection to reduce the burden on patients, providers, and sites, as well as the cost. Making broader adoption of such innovative trial designs a priority is particularly important for #raredisease patients given the small and geographically dispersed patient populations, heterogenous disease manifestations, and challenges that make it hard for many in our community to travel long distances. Kudos to #FDA for standing up #C3TI, the #CDER Center for Clinical Trial Innovation.